RNA-seq of iPSC-ECs treated under normoglycemic and hyperglycemic conditions with and without MDL-28170 treatment
收藏NIAID Data Ecosystem2026-04-30 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP173327
下载链接
链接失效反馈官方服务：
资源简介：
Two healthy iPSC lines were differentiated into ECs. iPSC-ECs were then treated under normoglycemic (5.5mM glucose) or hyperglycemic (33mM glucose) conditions with and without MDL-28170 (2.5 uM) for 72 hours. Overall design: RNA-seq of iPSC-ECs under normoglycemia or hyperglycemia; with and without calpain inhibition (MDL-28170) over a period of 72 hours.
创建时间：
2023-01-11
